Oxford Immunotec Global PLC EV/EBIT
Cos'è EV/EBIT di Oxford Immunotec Global PLC?
EV/EBIT di Oxford Immunotec Global PLC è N/A
Qual è la definizione di EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT di aziende nel Health Care settore su NASDAQ rispetto a Oxford Immunotec Global PLC
Aziende con ev/ebit simili a Oxford Immunotec Global PLC
- Pathfinder Ventures ha EV/EBIT di N/A
- Immucell ha EV/EBIT di N/A
- Castile Resources ha EV/EBIT di N/A
- Blue Blends (India) ha EV/EBIT di N/A
- Puxin ha EV/EBIT di N/A
- Ansal Properties & Infrastructure ha EV/EBIT di N/A
- Oxford Immunotec Global PLC ha EV/EBIT di N/A
- Summit Midstream Partners LP ha EV/EBIT di N/A
- Goliath Resources ha EV/EBIT di N/A
- Affirm ha EV/EBIT di N/A
- Spey Resources Corp ha EV/EBIT di N/A
- Radaan Mediaworks India ha EV/EBIT di N/A
- Impact Acquisitions ha EV/EBIT di N/A